Outcomes of patients with initially unresectable pancreatic cancer who underwent conversion surgery after FOLFIRINOX or gemcitabine plus nab-paclitaxel chemotherapy: A multicenter retrospective cohort study (PC-CURE-1).

Naohiro Okano Manabu KawaiMakoto UenoXianjun YuYosuke Inoue Shinichiro TakahashiWenquan WangHidenori TakahashiYukiyasu OkamuraSoichiro MorinagaIppei Matsumoto Yasuhiro ShimizuKazuhiro YoshidaTomohisa YamamotoMasayuki OhtsukaYoshikuni Inokawa Satoshi NaraJun TamuraSatoru ShinodaKouji YamamotoHiroki YamaueJunji Furusenull null

Published in: Journal of hepato-biliary-pancreatic sciences (2024)

CS, following a favorable response to FOLFIRINOX or GnP chemotherapy, improved initially unresectable PC prognosis (specifically, OS), regardless of the chemotherapy duration.

Keyphrases

locally advanced
rectal cancer
squamous cell carcinoma
radiation therapy
minimally invasive
coronary artery bypass
clinical trial
metabolic syndrome
type diabetes
atrial fibrillation
advanced non small cell lung cancer
adipose tissue
weight loss